Ann: Parkway achieves ISO Accreditation, page-9

Nice to see some sensible discussion occurring here. I agree entirely about where PWN is positioned at the moment. Its still in an embryonic stage but like all industry is currently being held back by focus on Covid, resource problems and reticence by potential customers to invest in new technology with so much instability. Once most of these problems are stabilised or overcome there will be a return of focus on ESG which was trending pre-Covid period. PWN is operating in a niche field with good IP, proof of concept, ongoing research with University collaboration and a revenue source to keep it mostly funded. Sounds like a well oiled machine to me - just need a bit of patience holders to get all the cogs turning. Changed sentiment to buy based on post-Covid chances.